We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $14.1B
1-Year Est. Return 30.11%
This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$14.1B
AUM Growth
+$741M
Cap. Flow
+$1.58B
Cap. Flow %
11.22%
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$110M
2
AAPL icon
Apple
AAPL
+$89M
3
MSFT icon
Microsoft
MSFT
+$81.1M
4
AMZN icon
Amazon
AMZN
+$54.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$45.4M

Sector Composition

Rank Sector Weight
1 Technology 35.95%
2 Financials 11.04%
3 Consumer Discretionary 10.63%
4 Communication Services 10.59%
5 Healthcare 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLK icon
1051
Westlake Corp
WLK
$9.87B
$466K ﹤0.01%
3,988
+887
+29% +$86K
LNC icon
1052
Lincoln National
LNC
$7.97B
$465K ﹤0.01%
13,092
+3,474
+36% +$133K
EXPO icon
1053
Exponent
EXPO
$2.95B
$463K ﹤0.01%
7,100
+989
+16% +$70.3K
KBH icon
1054
KB Home
KBH
$3.46B
$462K ﹤0.01%
8,933
+1,193
+15% +$70.2K
KMX icon
1055
CarMax
KMX
$8.15B
$461K ﹤0.01%
11,085
+3,267
+42% +$143K
TERN
1056
DELISTED
Terns Pharmaceuticals
TERN
$459K ﹤0.01%
8,709
+2,032
+30% +$83.5K
EPR icon
1057
EPR Properties
EPR
$4.75B
$457K ﹤0.01%
9,155
+2,149
+31% +$118K
MKTX icon
1058
MarketAxess Holdings
MKTX
$4.01B
$457K ﹤0.01%
2,769
+838
+43% +$147K
TGTX icon
1059
TG Therapeutics
TGTX
$8.06B
$454K ﹤0.01%
13,679
+2,161
+19% +$64.4K
SAP icon
1060
SAP
SAP
$174B
$451K ﹤0.01%
2,634
+604
+30% +$125K
JOBY icon
1061
Joby Aviation
JOBY
$7.51B
$448K ﹤0.01%
54,287
+16,226
+43% +$183K
KYMR icon
1062
Kymera Therapeutics
KYMR
$9.08B
$448K ﹤0.01%
5,374
+869
+19% +$68.8K
PECO icon
1063
Phillips Edison & Co
PECO
$5.46B
$447K ﹤0.01%
11,935
+1,935
+19% +$71.9K
PTEN icon
1064
Patterson-UTI
PTEN
$4.07B
$445K ﹤0.01%
41,101
+14,104
+52% +$121K
GTES icon
1065
Gates Industrial Corporation Ltd.
GTES
$6.96B
$445K ﹤0.01%
19,672
+5,880
+43% +$143K
KRC icon
1066
Kilroy Realty
KRC
$4.49B
$445K ﹤0.01%
15,760
+3,259
+26% +$107K
RYTM icon
1067
Rhythm Pharmaceuticals
RYTM
$7.13B
$434K ﹤0.01%
4,990
+721
+17% +$70.1K
HASI icon
1068
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
$432K ﹤0.01%
11,757
+2,064
+21% +$73.5K
BOOT icon
1069
Boot Barn
BOOT
$4.53B
$432K ﹤0.01%
2,950
+474
+19% +$85.9K
COMP icon
1070
Compass
COMP
$8.41B
$432K ﹤0.01%
59,053
+20,518
+53% +$216K
UMC icon
1071
United Microelectronic
UMC
$53.4B
$431K ﹤0.01%
47,952
+27,458
+134% +$268K
GFS icon
1072
GlobalFoundries
GFS
$32.1B
$429K ﹤0.01%
9,653
+3,725
+63% +$164K
SAN icon
1073
Banco Santander
SAN
$197B
$429K ﹤0.01%
38,009
+9,334
+33% +$111K
SHG icon
1074
Shinhan Financial Group
SHG
$33.2B
$428K ﹤0.01%
6,984
+3,142
+82% +$193K
LBRT icon
1075
Liberty Energy
LBRT
$4.1B
$425K ﹤0.01%
14,772
+2,342
+19% +$59.7K

Similar funds

Xponance's Q1 2026 Portfolio in Review

As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.

  • Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
  • Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
  • Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
  • Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
  • Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
  • Xponance opened 165 new positions and closed 49 in Q1 2026.
  • Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.